Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:55 AM
Ignite Modification Date:
2025-12-24 @ 11:55 AM
NCT ID:
NCT03149861
Eligibility Criteria:
Inclusion Criteria:
* Patients accrued will fit any of the following criteria:
1. Clinical suspicion of PCa with negative TRUS-guided biopsy or clinically discordant low-risk PCa (suspicion of more extensive/aggressive disease).
2. Potential candidates for FT (as per institutional guidelines).
Exclusion Criteria:
Patients will be ineligible to participate in this study if they meet any of the following criteria:
1. Contraindication for MR as per current institutional guidelines.
2. Contraindication for Gadolinium injection as per current institutional guidelines.
3. Inability to lie supine for at least 60 minutes.
4. Prostate biopsy \<8 weeks prior to planned PET-MR.
Healthy Volunteers:
False
Sex:
MALE
Minimum Age:
18 Years
Study:
NCT03149861
Study Brief:
Protocol Section:
NCT03149861